Envista Holdings Co. (NYSE:NVST) Short Interest Update

Envista Holdings Co. (NYSE:NVST) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 12,270,000 shares, a decline of 20.3% from the October 15th total of 15,390,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the short-interest ratio is currently 5.1 days.

Envista Trading Up 2.4 %

Shares of Envista stock traded up $0.49 during trading hours on Friday, hitting $20.57. The company’s stock had a trading volume of 1,874,091 shares, compared to its average volume of 2,411,125. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $3.54 billion, a PE ratio of -2.58, a P/E/G ratio of 2.83 and a beta of 1.30. The business has a fifty day moving average of $19.13 and a 200 day moving average of $18.13. Envista has a 1-year low of $15.15 and a 1-year high of $25.64.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. The business had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business’s revenue was down 4.8% on a year-over-year basis. During the same period last year, the business earned $0.43 EPS. As a group, equities analysts forecast that Envista will post 0.72 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Leerink Partnrs raised shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Wells Fargo & Company began coverage on Envista in a research report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 price objective on the stock. Evercore ISI upped their target price on Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Stifel Nicolaus lifted their price target on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. downgraded shares of Envista from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Envista currently has a consensus rating of “Hold” and a consensus target price of $20.71.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Envista during the 3rd quarter worth about $31,000. GAMMA Investing LLC lifted its holdings in shares of Envista by 69.8% in the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares in the last quarter. Huntington National Bank boosted its position in shares of Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after buying an additional 949 shares during the period. Blue Trust Inc. grew its holdings in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after buying an additional 804 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after acquiring an additional 728 shares during the period.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.